Biomedical Engineering Reference
In-Depth Information
ef ect of ATRA, As2O3, phenylbutyrate, and G-CSF in acute promyelocytic leukemia.
Haematologica 92: 1615-1622.
Delforge, M. and V. Raets, V. Van Duppen, P. Vandenberghe, and M. Boogaerts. 2005.
CD34+ marrow progenitors from MDS patients with high levels of intramedullary
apoptosis have reduced expression of alpha4beta1 and alpha5beta1 integrins. Leukemia
19: 57-63.
Di Noto, R. and E.M. Schiavone, F. Ferrara, C. Manzo, C. Lo Pardo, and L. Del Vecchio. 1994.
Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic
leukemia. Leukemia
8: 1900-1905.
Dore A.I. and B.A.A. Santana-Lemos, V.M. Coser, F.L.S. Santos, L.F. Dalmazzo, A.S.G. Lima,
R.H. Jacomo, J. Elias, Jr., R.P. Falcão,
W.V. Pereira and E.M. Rego. 2007.
h e association
of ICAM-1 Exon 6 (E469K) but not of ICAM-1 Exon 4 (G241R) and PECAM-1 Exon
3 (L125V) polymorphisms with the development of dif erentiation syndrome in acute
promyelocytic leukemia. J. Leukoc. Biol. 82: 1340-1343.
Gallay, N. and L. Anani, A. Lopez, P. Colombat, C. Binet, J. Domenech, B.B. Weksler,
F. Malavasi and O. Herault. 2007. h e role of platelet/endothelial cell adhesion
molecule-1 (CD31) and CD38 antigens in marrow microenvironmental retention of
acute myelogenous leukemia cells. Cancer Res. 16: 8624-8632.
Haug, J.S. and X.C. He, J.C. Grindley, J.P. Wunderlich, K. Gaudenz, J.T. Ross, A. Paulson, K.P.
Wagner, Y. Xie, R. Zhu, T. Yin, J.M. Perry, M.J. Hembree, E.P. Redenbaugh, G.L. Radice, C.
Seidel and L. Li. 2008. N-cadherin expression level distinguishes reserved versus primed
states of hematopoietic stem cells. Cancer Stem Cell 2: 367-379.
Jin, L. and K.J. Hope, Q. Zhai, F. Smadja-Jof e, and J.E. Dick. 2006. Targeting of CD44
eradicates human acute myeloid leukemic stem cells. Nat. Med. 12: 1167-1174.
Kiel, M.J. and M. Acar, G.L. Radice, and S.J. Morrison. 2009. Hematopoietic stem cells do
not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 4: 170-179.
Kollet, O. and A. Spiegel, A. Peled, I. Petit, T. Byk, R. Hershkoviz, E. Guetta, G. Barkai,
A. Nagler and T. Lapidot. 2001. Rapid and ei cient homing of human CD34(+)CD38(-/
low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID
and NOD/SCID/B2m(null) mice. Blood 97: 3283-3291.
Legras, S. and U. Günthert, R. Stauder, F. Curt, S. Oliferenko, H.C. Kluin-Nelemans,
J.P. Marie, S. Proctor, C. Jasmin and F. Smadja-Jof e. 1998. A strong expression of CD44-
6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 91:
3401-3413.
Matsunaga, T. and N. Takemoto, T. Sato, R. Takimoto, I. Tanaka, A. Fujimi, T. Akiyama,
H. Kuroda, Y. Kawano, M. Kobune, J. Kato, Y. Hirayama, S. Sakamaki, K. Kohda,
K. Miyake and Y. Niitsu. 2003. Interaction between leukemic-cell VLA-4 and stromal
i bronectin is a decisive factor for minimal residual disease of acute myelogenous
leukemia. Nat. Med. 9: 1158-1165.
Potocnik, A.J. and C. Brakebusch, and R. Fässler. 2000. Fetal and adult hematopoietic stem
cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow.
Immunity 12: 653-663.
Raspadori, D. and F. Lauria, M.A. Ventura, D. Rondelli, G. Visani, A. Vivo, and S. Tura.
1997. Incidence and prognostic relevance of CD34 expression in acute myeloblastic
leukemia: Analysis of 141 cases. Leuk. Res. 21: 603-607.
